Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.
(Q46708758)
scientific article published on 10 March 2008
scientific article published on 10 March 2008
Language:
other details
description | scientific article published on 10 March 2008 |
External Links
(P356) |
10.1200/JCO.2007.14.5482
|
(P698) |
18332469
|